Blood Products Advisory Committee
Executive Summary
Will meet Jan. 17 to discuss health issues concerning Yersinia infections in blood donations, donor deferral issues, and proposed criteria for an HIV "look-back" concerning products and recipient notification. On Jan. 18, the committee will address the premarket approval of Abbott's anti-hepatitis B core assay (anti-HBc) IgM test kit and anti-HBc donor deferral and re-entry issues. The committee will also discuss blood product safety issues concerning anti-Hepatitis C virus testing in source plasma donors. The meeting begins at 8:00 a.m. at the Ramada Inn in Bethesda, Md.